SUBSCRIBE
SUBSCRIBE
News   Policy

Pfizer Says UK Patients Are Denied Alzheimer Drugs

October 19, 2005 | 
1 min read

Britons suffering from Alzheimer’s disease are being denied drugs that can delay disease progression, according to a study by drugmaker Pfizer Inc (PFE.N: Quote, Profile, Research) showing significant regional variations in spending.

Regulatory Europe
Pfizer
MORE ON THIS TOPIC
Minimal Clip Art Collage. Pop Vector Design Composition with bright bold geometric shapes, halftone objects for ad, animation etc
Approvals
First Commissioner’s Priority Review Approval Goes to Decades-Old Antibiotic
December 10, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
Weight Loss Waves, Pazdur’s Exit and FDA Instability, New Neuro Breakthroughs
December 10, 2025
 · 
1 min read
 · 
Heather McKenzie
Two businessmen negotiating with big speech bubbles
Rare diseases
Saol To Pitch Ultrarare Disease Drug as “Poster Child” for RDEP Program
December 9, 2025
 · 
2 min read
 · 
Heather McKenzie
FDA signage at its headquarters in Maryland
FDA
CAR-T Developers Will Need Randomized Trials as FDA Eyes Tighter Approval Requirements
December 9, 2025
 · 
2 min read
 · 
Tristan Manalac